/
Stock
/
/

ALPINE IMMUNE SCIENCES

ALPN Insider Trades:
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2024-05-20
2024-05-20
TOPPER JAMES
D - Sale to Issuer
Stock Option (Right to buy)
-68,100
7
$650.9M
2024-05-20
2024-05-20
GOLD MITCHELL
Executive Chairman and CEO
D - Sale to Issuer
Common Stock
-109K
2
$650.9M
2024-05-20
2024-05-20
PENG STANFORD
President & Head of Research a...
D - Sale to Issuer
Common Stock
-344K
2
$650.9M
2024-05-20
2024-05-20
RICKEY JAMES PAUL
Senior Vice President, Chief F...
D - Sale to Issuer
Stock Option (Right to buy)
-415K
8
$650.9M
2024-05-20
2024-05-20
RICKEY JAMES PAUL
Senior Vice President, Chief F...
D - Sale to Issuer
Common Stock
-57,961
2
$650.9M
2024-05-20
2024-05-20
THOMPSON PETER
D - Sale to Issuer
Stock Option (Right to buy)
-68,100
7
$650.9M
2024-05-20
2024-05-20
GOLD MITCHELL
Executive Chairman and CEO
D - Sale to Issuer
Stock Option (Right to buy)
-2.04M
9
$650.9M
2024-05-20
2024-05-20
CONWAY ROBERT
D - Sale to Issuer
Stock Option (Right to buy)
-75,955
10
$650.9M
2024-05-20
2024-05-20
CONWAY ROBERT
D - Sale to Issuer
Common Stock
-50,000
1
$650.9M
2024-05-20
2024-05-20
CUI XIANGMIN
D - Sale to Issuer
Stock Option (Right to buy)
-60,450
6
$650.9M
2024-05-20
2024-05-20
DRAPPA JORN
D - Sale to Issuer
Stock Option (Right to buy)
-47,500
3
$650.9M
2024-05-20
2024-05-20
DURAND REMY
Chief Business Officer
D - Sale to Issuer
Stock Option (Right to buy)
-399K
6
$650.9M
2024-05-20
2024-05-20
DURAND REMY
Chief Business Officer
D - Sale to Issuer
Common Stock
-133K
2
$650.9M
2024-05-20
2024-05-20
FUHS ULRICH MARTIN
Chief Accounting Officer
D - Sale to Issuer
Stock Option (Right to buy)
-95,480
3
$650.9M
2024-05-20
2024-05-20
FUHS ULRICH MARTIN
Chief Accounting Officer
D - Sale to Issuer
Common Stock
-30,120
2
$650.9M
2024-05-20
2024-05-20
HERNDAY NATASHA
D - Sale to Issuer
Stock Option (Right to buy)
-60,150
5
$650.9M
2024-05-20
2024-05-20
PEETZ CHRISTOPHER
D - Sale to Issuer
Stock Option (Right to buy)
-68,100
7
$650.9M
2024-05-20
2024-05-20
PEETZ CHRISTOPHER
D - Sale to Issuer
Common Stock
-1,900
1
$650.9M
2024-05-20
2024-05-20
PENG STANFORD
President & Head of Research a...
D - Sale to Issuer
Stock Option (Right to buy)
-1.11M
9
$650.9M
2024-05-18
2024-05-20
CUI XIANGMIN
U - Disposition
Common Stock
-8.32M
2
$650.9M
2024-05-18
2024-05-20
ORBIMED ADVISORS LLC
U - Disposition
Common Stock
-2.68M
2
$650.9M
2024-05-18
2024-05-20
THOMPSON PETER
U - Disposition
Common Stock
-2.68M
2
$650.9M
2024-05-18
2024-05-20
TOPPER JAMES
U - Disposition
Common Stock
-2.83M
1
$650.9M
2024-05-18
2024-05-20
GOLD MITCHELL
Executive Chairman and CEO
U - Disposition
Common Stock
-2.63M
1
$650.9M
2024-05-08
2024-05-10
FUHS ULRICH MARTIN
Chief Accounting Officer
M - Exercise
Stock Option (Right to buy)
-22,820
$0.00
1
$650.9M
2024-05-08
2024-05-10
DURAND REMY
Chief Business Officer
M - Exercise
Stock Option (Right to buy)
-95,288
$0.00
5
$650.9M
2024-05-08
2024-05-10
DURAND REMY
Chief Business Officer
M - Exercise
Common Stock
95,288
$5.00
476K
5
$650.9M
2024-05-08
2024-05-10
FUHS ULRICH MARTIN
Chief Accounting Officer
M - Exercise
Common Stock
22,820
$12.00
274K
1
$650.9M
2024-05-08
2024-05-10
GOLD MITCHELL
Executive Chairman and CEO
M - Exercise
Stock Option (Right to buy)
-13,245
$0.00
1
$650.9M
2024-05-08
2024-05-10
GOLD MITCHELL
Executive Chairman and CEO
M - Exercise
Common Stock
13,245
$8.00
106K
1
$650.9M
2024-05-08
2024-05-10
PENG STANFORD
M - Exercise
Stock Option (Right to buy)
-272K
$0.00
7
$650.9M
2024-05-08
2024-05-10
PENG STANFORD
M - Exercise
Common Stock
272K
$2.00
544K
7
$650.9M
2024-05-07
2024-05-09
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Stock Option (Right to buy)
-26,761
$0.00
6
$650.9M
2024-05-07
2024-05-09
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Common Stock
26,761
$6.00
161K
6
$650.9M
2024-04-25
2024-04-29
TOPPER JAMES
S - Sale
Common Stock
-19
$65.00
-1,235
1
$650.9M
2024-04-25
2024-04-29
TOPPER JAMES
X - Exercise
Warrant (Right to Buy)
-1.20M
$0.00
1
$650.9M
2024-04-25
2024-04-29
TOPPER JAMES
X - Exercise
Common Stock
1.20M
$0.00
1
$650.9M
2024-01-26
2024-01-29
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Common Stock
118K
$8.00
942K
2
$650.9M
2024-01-26
2024-01-29
RICKEY JAMES PAUL
Senior Vice President, Chief F...
S - Sale
Common Stock
-118K
$23.00
-2.71M
2
$650.9M
2024-01-26
2024-01-29
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Stock Option (Right to buy)
-118K
$0.00
2
$650.9M
2024-01-25
2024-01-29
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Common Stock
236
$7.00
1,652
1
$650.9M
2024-01-25
2024-01-29
RICKEY JAMES PAUL
Senior Vice President, Chief F...
S - Sale
Common Stock
-236
$22.00
-5,192
1
$650.9M
2024-01-25
2024-01-29
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Stock Option (Right to buy)
-236
$0.00
1
$650.9M
2024-01-26
2024-01-26
RICKEY JAMES PAUL
Senior Vice President, Chief F...
S - Sale
-44,000
$22.00
-968K
1
$650.9M
2024-01-25
2024-01-25
RICKEY JAMES PAUL
Senior Vice President, Chief F...
S - Sale
-74,000
$19.00
-1.41M
1
$650.9M
2024-01-18
2024-01-22
CUI XIANGMIN
X - Exercise
Warrant (right to buy)
-1.23M
$0.00
1
$650.9M
2024-01-18
2024-01-22
CUI XIANGMIN
X - Exercise
Common Stock
1.23M
$13.00
16M
1
$650.9M
2024-01-18
2024-01-22
DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND III, L.P.
X - Exercise
Warrant (right to buy)
-1.23M
$0.00
1
$650.9M
2024-01-18
2024-01-22
DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND III, L.P.
X - Exercise
Common Stock
1.23M
$13.00
16M
1
$650.9M
2024-01-11
2024-01-16
ORBIMED ADVISORS LLC
X - Exercise
Common Stock
145K
$13.00
1.89M
1
$650.9M
2024-01-11
2024-01-16
THOMPSON PETER
X - Exercise
Warrant (Right to Buy)
-145K
$0.00
1
$650.9M
2024-01-11
2024-01-16
ORBIMED ADVISORS LLC
X - Exercise
Warrant (Right to Buy)
-145K
$0.00
1
$650.9M
2024-01-11
2024-01-16
THOMPSON PETER
X - Exercise
Common Stock
145K
$13.00
1.89M
1
$650.9M
2024-01-04
2024-01-05
RICKEY JAMES PAUL
Senior Vice President, Chief F...
A - Grant
Stock Option (Right to buy)
78,000
$0.00
1
$650.9M
2024-01-04
2024-01-05
GOLD MITCHELL
Executive Chairman and CEO
A - Grant
Common Stock
96,000
$0.00
1
$650.9M
2024-01-04
2024-01-05
PENG STANFORD
President & Head of Research a...
A - Grant
Stock Option (Right to buy)
120K
$0.00
1
$650.9M
2024-01-04
2024-01-05
PENG STANFORD
President & Head of Research a...
A - Grant
Common Stock
48,000
$0.00
1
$650.9M
2024-01-04
2024-01-05
DURAND REMY
Chief Business Officer
A - Grant
Stock Option (Right to buy)
78,000
$0.00
1
$650.9M
2024-01-04
2024-01-05
DURAND REMY
Chief Business Officer
A - Grant
Common Stock
31,200
$0.00
1
$650.9M
2024-01-04
2024-01-05
GOLD MITCHELL
Executive Chairman and CEO
A - Grant
Stock Option (Right to buy)
240K
$0.00
1
$650.9M
2024-01-04
2024-01-05
RICKEY JAMES PAUL
Senior Vice President, Chief F...
A - Grant
Common Stock
31,200
$0.00
1
$650.9M
2024-01-02
2024-01-04
CUI XIANGMIN
A - Grant
Stock Option (Right to buy)
17,500
$0.00
1
$650.9M
2024-01-02
2024-01-04
DRAPPA JORN
A - Grant
Stock Option (Right to buy)
17,500
$0.00
1
$650.9M
2024-01-02
2024-01-04
CONWAY ROBERT
A - Grant
Stock Option (Right to buy)
17,500
$0.00
1
$650.9M
2024-01-02
2024-01-04
HERNDAY NATASHA
A - Grant
Stock Option (Right to buy)
17,500
$0.00
1
$650.9M
2024-01-02
2024-01-04
PEETZ CHRISTOPHER
A - Grant
Stock Option (Right to buy)
17,500
$0.00
1
$650.9M
2024-01-02
2024-01-04
THOMPSON PETER
A - Grant
Stock Option (Right to buy)
17,500
$0.00
1
$650.9M
2024-01-02
2024-01-04
TOPPER JAMES
A - Grant
Stock Option (Right to buy)
17,500
$0.00
1
$650.9M
2023-12-28
2023-12-29
GOLD MITCHELL
Executive Chairman and CEO
M - Exercise
Common Stock
75,457
$13.00
981K
2
$650.9M
2023-12-28
2023-12-29
GOLD MITCHELL
Executive Chairman and CEO
F - Tax
Common Stock
-48,264
$20.00
-965K
1
$650.9M
2023-12-28
2023-12-29
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-1,016
$20.00
-20,320
1
$650.9M
2023-12-28
2023-12-29
GOLD MITCHELL
Executive Chairman and CEO
M - Exercise
Stock Option (Right to buy)
-1,016
$0.00
1
$650.9M
2023-12-28
2023-12-29
GOLD MITCHELL
Executive Chairman and CEO
M - Exercise
Warrant (right to buy)
-74,441
$0.00
1
$650.9M
2023-12-28
2023-12-29
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-1.36M
$18.00
-25M
4
$650.9M
2023-12-28
2023-12-29
THOMPSON PETER
S - Sale
Common Stock
-1.36M
$18.00
-25M
4
$650.9M
2023-12-27
2023-12-29
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-181K
$20.00
-3.63M
2
$650.9M
2023-12-27
2023-12-29
THOMPSON PETER
S - Sale
Common Stock
-181K
$20.00
-3.63M
2
$650.9M
2023-12-27
2023-12-27
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-29,573
$20.00
-591K
1
$650.9M
2023-12-27
2023-12-27
GOLD MITCHELL
Executive Chairman and CEO
M - Exercise
Common Stock
29,573
$1.00
29,573
1
$650.9M
2023-12-27
2023-12-27
GOLD MITCHELL
Executive Chairman and CEO
M - Exercise
Stock Option (Right to buy)
-29,573
$0.00
1
$650.9M
2023-12-27
2023-12-27
ORBIMED GENESIS MASTER FUND, L.P.
S - Sale
-161K
$20.00
-3.22M
1
$650.9M
2023-12-27
2023-12-27
ORBIMED PRIVATE INVESTMENTS VI, LP
S - Sale
-1.39M
$20.00
-28M
1
$650.9M
2023-12-26
2023-12-27
GOLD MITCHELL
Executive Chairman and CEO
M - Exercise
Common Stock
24,486
$1.00
24,486
2
$650.9M
2023-12-26
2023-12-27
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-24,486
$20.00
-490K
1
$650.9M
2023-12-26
2023-12-27
GOLD MITCHELL
Executive Chairman and CEO
M - Exercise
Stock Option (Right to buy)
-24,486
$0.00
2
$650.9M
2023-12-22
2023-12-27
GOLD MITCHELL
Executive Chairman and CEO
M - Exercise
Stock Option (Right to buy)
-37,825
$0.00
1
$650.9M
2023-12-22
2023-12-27
GOLD MITCHELL
Executive Chairman and CEO
M - Exercise
Common Stock
37,825
$0.00
1
$650.9M
2023-12-22
2023-12-27
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-37,825
$20.00
-757K
1
$650.9M
2023-12-19
2023-12-21
GOLD MITCHELL
Executive Chairman and CEO
M - Exercise
Stock Option (Right to buy)
-2,402
$0.00
1
$650.9M
2023-12-19
2023-12-21
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-2,402
$20.00
-48,040
1
$650.9M
2023-12-19
2023-12-21
RICKEY JAMES PAUL
Senior Vice President, Chief F...
S - Sale
Common Stock
-15,213
$19.00
-289K
1
$650.9M
2023-12-19
2023-12-21
GOLD MITCHELL
Executive Chairman and CEO
M - Exercise
Common Stock
2,402
$0.00
1
$650.9M
2023-12-19
2023-12-21
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Stock Option (Right to buy)
-15,213
$0.00
1
$650.9M
2023-12-19
2023-12-21
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Common Stock
15,213
$5.00
76,065
1
$650.9M
2023-12-19
2023-12-19
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
-120K
$20.00
-2.40M
1
$650.9M
2023-12-18
2023-12-18
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Stock Option (Right to buy)
-1,800
$0.00
1
$650.9M
2023-12-18
2023-12-18
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Common Stock
1,800
$5.00
9,000
1
$650.9M
2023-12-18
2023-12-18
RICKEY JAMES PAUL
Senior Vice President, Chief F...
S - Sale
Common Stock
-1,800
$19.00
-34,200
1
$650.9M
2023-12-15
2023-12-18
RICKEY JAMES PAUL
Senior Vice President, Chief F...
S - Sale
Common Stock
-45,387
$19.00
-862K
1
$650.9M
2023-12-15
2023-12-18
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Common Stock
45,387
$5.00
227K
1
$650.9M
2023-12-15
2023-12-18
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Stock Option (Right to buy)
-45,387
$0.00
1
$650.9M
2023-12-14
2023-12-18
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Stock Option (Right to buy)
-11,600
$0.00
1
$650.9M
2023-12-14
2023-12-18
RICKEY JAMES PAUL
Senior Vice President, Chief F...
S - Sale
Common Stock
-11,600
$19.00
-220K
1
$650.9M
2023-12-14
2023-12-18
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Common Stock
11,600
$5.00
58,000
1
$650.9M
2023-12-15
2023-12-15
RICKEY JAMES PAUL
Senior Vice President, Chief F...
S - Sale
-62,400
$19.00
-1.19M
1
$650.9M
2023-12-11
2023-12-13
TOPPER JAMES
X - Exercise
Common Stock
145K
$13.00
1.89M
1
$650.9M
2023-12-11
2023-12-13
TOPPER JAMES
X - Exercise
Warrant (Right to Buy)
-145K
$0.00
1
$650.9M
2023-12-12
2023-12-12
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-41,063
$17.00
-698K
2
$650.9M
2023-12-12
2023-12-12
GOLD MITCHELL
Executive Chairman and CEO
M - Exercise
Stock Option (Right to buy)
-8,613
$0.00
1
$650.9M
2023-12-12
2023-12-12
GOLD MITCHELL
Executive Chairman and CEO
M - Exercise
Common Stock
8,613
$0.00
1
$650.9M
2023-12-11
2023-12-12
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-68,870
$17.00
-1.17M
1
$650.9M
2023-12-08
2023-12-12
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-8,067
$17.00
-137K
1
$650.9M
2023-12-08
2023-12-08
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
-118K
$17.00
-2.01M
1
$650.9M
2023-12-06
2023-12-06
RICKEY JAMES PAUL
Senior Vice President, Chief F...
S - Sale
Common Stock
-6,446
$16.00
-103K
1
$650.9M
2023-12-06
2023-12-06
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Stock Option (Right to buy)
-6,446
$0.00
1
$650.9M
2023-12-06
2023-12-06
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Common Stock
6,446
$3.00
19,338
1
$650.9M
2023-12-05
2023-12-06
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Stock Option (Right to buy)
-418
$0.00
1
$650.9M
2023-12-05
2023-12-06
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Common Stock
418
$3.00
1,254
1
$650.9M
2023-12-05
2023-12-06
RICKEY JAMES PAUL
Senior Vice President, Chief F...
S - Sale
Common Stock
-418
$16.00
-6,688
1
$650.9M
2023-12-04
2023-12-06
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Common Stock
63,947
$3.00
192K
1
$650.9M
2023-12-04
2023-12-06
RICKEY JAMES PAUL
Senior Vice President, Chief F...
S - Sale
Common Stock
-63,947
$16.00
-1.02M
1
$650.9M
2023-12-04
2023-12-06
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Stock Option (Right to buy)
-63,947
$0.00
1
$650.9M
2023-11-30
2023-12-01
RICKEY JAMES PAUL
Senior Vice President, Chief F...
S - Sale
Common Stock
-700
$16.00
-11,200
1
$650.9M
2023-11-30
2023-12-01
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Common Stock
700
$3.00
2,100
1
$650.9M
2023-11-30
2023-12-01
RICKEY JAMES PAUL
Senior Vice President, Chief F...
M - Exercise
Stock Option (Right to buy)
-700
$0.00
1
$650.9M
2023-11-09
2023-11-14
CUI XIANGMIN
P - Purchase
Common Stock
375K
$13.00
4.88M
1
$650.9M
2023-11-09
2023-11-14
DECHENG CAPITAL GLOBAL HEALTHCARE FUND (MASTER), LP
P - Purchase
Common Stock
375K
$13.00
4.88M
1
$650.9M
2023-11-06
2023-11-08
RICKEY JAMES PAUL
M - Exercise
Stock Option (Right to buy)
-10,989
$0.00
1
$650.9M
2023-11-06
2023-11-08
RICKEY JAMES PAUL
S - Sale
Common Stock
-18,003
$16.00
-288K
1
$650.9M
2023-11-06
2023-11-08
RICKEY JAMES PAUL
M - Exercise
Common Stock
10,989
$3.00
32,967
1
$650.9M
2023-11-06
2023-11-06
RICKEY JAMES PAUL
Senior Vice President, Chief F...
S - Sale
-89,514
$16.00
-1.43M
1
$650.9M
2023-10-02
2023-10-04
DUMMER WOLFGANG
Chief Medical Officer
A - Grant
Stock Option (Right to buy)
200K
$0.00
1
$650.9M
2023-01-05
2023-01-05
SANDLER ANDREW SETH
Chief Medical Officer
A - Grant
Stock Option (Right to buy)
50,000
$0.00
1
$650.9M
2023-01-04
2023-01-05
GOLD MITCHELL
Executive Chairman and CEO
A - Grant
Stock Option (Right to buy)
350K
$0.00
1
$650.9M
2023-01-04
2023-01-05
PENG STANFORD
President & Head of Research D...
A - Grant
Stock Option (Right to buy)
150K
$0.00
1
$650.9M
2023-01-04
2023-01-05
RICKEY JAMES PAUL
Senior Vice President, Chief F...
A - Grant
Stock Option (Right to buy)
109K
$0.00
1
$650.9M
2023-01-03
2023-01-05
DRAPPA JORN
A - Grant
Stock Option (Right to buy)
10,000
$0.00
1
$650.9M
2023-01-03
2023-01-05
CONWAY ROBERT
A - Grant
Stock Option (Right to buy)
10,000
$0.00
1
$650.9M
2023-01-03
2023-01-05
CUI XIANGMIN
A - Grant
Stock Option (Right to buy)
10,000
$0.00
1
$650.9M
2023-01-03
2023-01-05
HERNDAY NATASHA
A - Grant
Stock Option (Right to buy)
10,000
$0.00
1
$650.9M
2023-01-03
2023-01-05
PEETZ CHRISTOPHER
A - Grant
Stock Option (Right to buy)
10,000
$0.00
1
$650.9M
2023-01-03
2023-01-05
THOMPSON PETER
A - Grant
Stock Option (Right to buy)
10,000
$0.00
1
$650.9M
2023-01-03
2023-01-05
TOPPER JAMES
A - Grant
Stock Option (Right to buy)
10,000
$0.00
1
$650.9M
2022-09-23
2022-09-27
CUI XIANGMIN
A - Grant
Common Stock
2.00M
$7.00
14M
2
$650.9M
2022-09-23
2022-09-27
DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND III, L.P.
A - Grant
Common Stock
2.00M
$7.00
14M
2
$650.9M
2022-08-17
2022-08-18
SANDLER ANDREW SETH
Chief Medical Officer
A - Grant
Stock Option (Right to buy)
160K
$0.00
1
$650.9M
2022-07-18
2022-07-19
DRAPPA JORN
A - Grant
Stock Option (Right to buy)
20,000
$0.00
1
$650.9M
2022-07-15
2022-07-19
VENKATESAN JAY
M - Exercise
Stock Option (Right to buy)
-20,063
$0.00
1
$650.9M
2022-07-15
2022-07-19
VENKATESAN JAY
M - Exercise
Common Stock
20,063
$0.00
1
$650.9M
2022-02-11
2022-02-15
FRAZIER LIFE SCIENCES VIII, L.P.
P - Purchase
Common Stock
113K
$7.00
789K
1
$650.9M
2022-01-04
2022-01-06
GOLD MITCHELL
Executive Chairman and CEO
A - Grant
Stock Option (Right to buy)
215K
$0.00
1
$650.9M
2022-01-04
2022-01-06
RICKEY JAMES PAUL
Senior VP and CFO
A - Grant
Stock Option (Right to buy)
113K
$0.00
1
$650.9M
2022-01-04
2022-01-06
PENG STANFORD
President & Head of Research D...
A - Grant
Stock Option (Right to buy)
215K
$0.00
1
$650.9M
2022-01-03
2022-01-04
HERNDAY NATASHA
A - Grant
Stock Option (Right to buy)
10,000
$0.00
1
$650.9M
2022-01-03
2022-01-04
THOMPSON PETER
A - Grant
Stock Option (Right to buy)
10,000
$0.00
1
$650.9M
2022-01-03
2022-01-04
TOPPER JAMES
A - Grant
Stock Option (Right to buy)
10,000
$0.00
1
$650.9M
2022-01-03
2022-01-04
PEETZ CHRISTOPHER
A - Grant
Stock Option (Right to buy)
10,000
$0.00
1
$650.9M
2022-01-03
2022-01-04
CONWAY ROBERT
A - Grant
Stock Option (Right to buy)
10,000
$0.00
1
$650.9M
2022-01-03
2022-01-04
CUI XIANGMIN
A - Grant
Stock Option (Right to buy)
10,000
$0.00
1
$650.9M
2022-01-03
2022-01-04
VENKATESAN JAY
A - Grant
Stock Option (Right to buy)
10,000
$0.00
1
$650.9M
2021-12-31
2022-01-04
RICKEY JAMES PAUL
Senior VP and CFO
S - Sale
Common Stock
-17,013
$14.00
-238K
1
$650.9M
2021-09-23
2021-09-27
PEETZ CHRISTOPHER
P - Purchase
Common Stock
1,900
$10.00
19,000
1
$650.9M
2021-09-23
2021-09-27
CONWAY ROBERT
P - Purchase
Common Stock
15,000
$10.00
150K
1
$650.9M
2021-09-23
2021-09-24
CONWAY ROBERT
S - Sale
Common Stock
15,000
$10.00
150K
1
$650.9M
2021-09-23
2021-09-24
PEETZ CHRISTOPHER
S - Sale
Common Stock
1,900
$10.00
19,000
1
$650.9M
2021-09-21
2021-09-23
CONWAY ROBERT
P - Purchase
Common Stock
10,000
$10.00
100K
1
$650.9M
2021-09-17
2021-09-21
FRAZIER LIFE SCIENCES VIII, L.P.
A - Grant
Warrant (Right to Buy)
1.20M
$0.00
1
$650.9M
2021-09-17
2021-09-21
FRAZIER LIFE SCIENCES VIII, L.P.
D - Sale to Issuer
Common Stock
-1.20M
1
$650.9M
2021-09-17
2021-09-21
CUI XIANGMIN
P - Purchase
Common Stock
1.54M
$9.00
14M
1
$650.9M
2021-09-17
2021-09-21
DECHENG CAPITAL CHINA LIFE SCIENCES USD FUND III, L.P.
P - Purchase
Common Stock
1.54M
$9.00
14M
1
$650.9M
2021-09-17
2021-09-21
ORBIMED ADVISORS LLC
P - Purchase
Common Stock
1.01M
$9.00
9.10M
2
$650.9M
2021-09-17
2021-09-21
ALPINE IMMUNOSCIENCES, L.P.
S - Sale
Common Stock
-400K
$9.00
-3.60M
1
$650.9M
2021-09-17
2021-09-21
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-445K
$9.00
-4.01M
2
$650.9M
2021-09-17
2021-09-21
VENKATESAN JAY
S - Sale
Common Stock
-400K
$9.00
-3.60M
1
$650.9M
2021-09-17
2021-09-21
THOMPSON PETER
P - Purchase
Common Stock
1.01M
$9.00
9.10M
2
$650.9M
2021-09-16
2021-09-17
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-6,768
$10.00
-67,680
1
$650.9M
2021-09-15
2021-09-17
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-3,484
$10.00
-34,840
1
$650.9M
2021-06-28
2021-06-29
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-3,479
$10.00
-34,790
1
$650.9M
2021-06-25
2021-06-29
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-9,473
$10.00
-94,730
1
$650.9M
2021-06-01
2021-06-02
GOLDBERG ZELANNA
Chief Medical Officer
A - Grant
Stock Option (Right to buy)
160K
$0.00
1
$650.9M
2021-05-20
2021-05-21
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-1,221
$15.00
-18,315
1
$650.9M
2021-05-19
2021-05-21
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-50,965
$15.00
-764K
1
$650.9M
2021-05-13
2021-05-14
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-10,000
$12.00
-120K
1
$650.9M
2021-05-12
2021-05-14
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-10,000
$12.00
-120K
1
$650.9M
2021-03-31
2021-04-23
VENKATESAN JAY
M - Exercise
Stock Option (Right to buy)
-7,650
$0.00
1
$650.9M
2021-03-31
2021-04-23
VENKATESAN JAY
M - Exercise
Common Stock
7,650
$4.00
30,600
1
$650.9M
2021-03-30
2021-04-23
VENKATESAN JAY
M - Exercise
Stock Option (Right to buy)
-7,650
$0.00
1
$650.9M
2021-03-30
2021-04-23
VENKATESAN JAY
M - Exercise
Common Stock
7,650
$4.00
30,600
1
$650.9M
2021-04-14
2021-04-15
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-10,000
$11.00
-110K
1
$650.9M
2021-04-13
2021-04-15
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-10,000
$10.00
-100K
1
$650.9M
2021-03-05
2021-03-08
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-10,000
$13.00
-130K
1
$650.9M
2021-03-04
2021-03-08
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-10,000
$13.00
-130K
1
$650.9M
2021-02-02
2021-02-03
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-10,000
$12.00
-120K
1
$650.9M
2021-02-01
2021-02-03
GOLD MITCHELL
Executive Chairman and CEO
S - Sale
Common Stock
-10,000
$13.00
-130K
2
$650.9M
2021-01-05
2021-01-06
GOLD MITCHELL
Executive Chairman and CEO
A - Grant
Stock Option (Right to buy)
255K
$0.00
1
$650.9M
2021-01-05
2021-01-06
PENG STANFORD
President & Head of Research a...
A - Grant
Stock Option (Right to buy)
150K
$0.00
1
$650.9M
2021-01-05
2021-01-06
RICKEY JAMES PAUL
Senior VP and CFO
A - Grant
Stock Option (Right to buy)
120K
$0.00
1
$650.9M
2021-01-04
2021-01-05
TOPPER JAMES
A - Grant
Stock Option (Right to buy)
7,650
$0.00
1
$650.9M
2021-01-04
2021-01-05
VENKATESAN JAY
A - Grant
Stock Option (Right to buy)
7,650
$0.00
1
$650.9M
2021-01-04
2021-01-05
CONWAY ROBERT
A - Grant
Stock Option (Right to buy)
7,650
$0.00
1
$650.9M
2021-01-04
2021-01-05
CUI XIANGMIN
A - Grant
Stock Option (Right to buy)
7,650
$0.00
1
$650.9M
2021-01-04
2021-01-05
HERNDAY NATASHA
A - Grant
Stock Option (Right to buy)
7,650
$0.00
1
$650.9M
2021-01-04
2021-01-05
PEETZ CHRISTOPHER
A - Grant
Stock Option (Right to buy)
7,650
$0.00
1
$650.9M
2021-01-04
2021-01-05
THOMPSON PETER
A - Grant
Stock Option (Right to buy)
7,650
$0.00
1
$650.9M
2020-12-31
2021-01-04
RICKEY JAMES PAUL
Senior VP and CFO
F - Tax
Common Stock
-2,258
$13.00
-29,354
1
$650.9M
2020-12-31
2021-01-04
GOLD MITCHELL
Executive Chairman and CEO
F - Tax
Common Stock
-11,123
$13.00
-145K
1
$650.9M
2020-12-31
2021-01-04
PENG STANFORD
President & Head of Research a...
F - Tax
Common Stock
-3,923
$13.00
-50,999
1
$650.9M
2020-12-28
2020-12-30
THOMPSON PETER
S - Sale
Common Stock
-600K
$14.00
-8.40M
1
$650.9M
2020-12-28
2020-12-30
ORBIMED ADVISORS LLC
S - Sale
Common Stock
-600K
$14.00
-8.40M
1
$650.9M
2020-12-22
2020-12-22
ALPINE IMMUNOSCIENCES, L.P.
J - Other
Common Stock
-994K
$0.00
1
$650.9M
2020-12-22
2020-12-22
GOLD MITCHELL
Executive Chairman and CEO
J - Other
Common Stock
261K
$0.00
1
$650.9M
2020-12-22
2020-12-22
GOLD MITCHELL
Executive Chairman and CEO
J - Other
Common Stock
-994K
$0.00
1
$650.9M
2020-12-22
2020-12-22
VENKATESAN JAY
J - Other
Common Stock
181K
$0.00
1
$650.9M
2020-12-22
2020-12-22
VENKATESAN JAY
J - Other
Common Stock
-994K
$0.00
1
$650.9M
2020-12-10
2020-12-11
HERNDAY NATASHA
A - Grant
Stock Option (right to buy)
15,000
$0.00
1
$650.9M
2020-11-19
2020-11-23
CONWAY ROBERT
P - Purchase
Common Stock
10,000
$8.00
80,000
1
$650.9M
2020-07-08
2020-07-09
PENG STANFORD
President & Head of Research a...
A - Grant
Stock Option (right to buy)
50,000
$0.00
1
$650.9M
2020-06-30
2020-07-01
GOLD MITCHELL
Executive Chairman and CEO
F - Tax
Common Stock
-8,227
$10.00
-82,270
1
$650.9M
2020-06-30
2020-07-01
PENG STANFORD
President & Head of Research a...
F - Tax
Common Stock
-3,923
$10.00
-39,230
1
$650.9M
2020-06-30
2020-07-01
RICKEY JAMES PAUL
Senior VP and CFO
F - Tax
Common Stock
-2,258
$10.00
-22,580
1
$650.9M
2020-01-23
2020-01-27
PENG STANFORD
President & Head of R&D
A - Grant
Common Stock
32,217
$0.00
1
$650.9M
2020-01-23
2020-01-27
RICKEY JAMES PAUL
Senior VP and CFO
A - Grant
Common Stock
18,543
$0.00
1
$650.9M
2020-01-23
2020-01-27
GOLD MITCHELL
Executive Chairman and CEO
A - Grant
Stock Option (right to buy)
270K
$0.00
1
$650.9M
2020-01-23
2020-01-27
GOLD MITCHELL
Executive Chairman and CEO
A - Grant
Common Stock
67,569
$0.00
1
$650.9M
2020-01-23
2020-01-27
PENG STANFORD
President & Head of R&D
A - Grant
Stock Option (right to buy)
108K
$0.00
1
$650.9M
2020-01-23
2020-01-27
RICKEY JAMES PAUL
Senior VP and CFO
A - Grant
Stock Option (right to buy)
102K
$0.00
1
$650.9M
2019-12-23
2020-01-27
GOLD MITCHELL
Executive Chairman and CEO
G - Gift
Common Stock
-5,000
$0.00
1
$650.9M
2019-12-11
2020-01-27
GOLD MITCHELL
Executive Chairman and CEO
G - Gift
Common Stock
-5,000
$0.00
1
$650.9M
2020-01-02
2020-01-06
CONWAY ROBERT
A - Grant
Stock Option (Right to buy)
7,650
$0.00
1
$650.9M
2020-01-02
2020-01-06
CUI XIANGMIN
A - Grant
Stock Option (Right to buy)
7,650
$0.00
1
$650.9M
2020-01-02
2020-01-06
PEETZ CHRISTOPHER
A - Grant
Stock Option (Right to buy)
7,650
$0.00
1
$650.9M
2020-01-02
2020-01-06
SEKHRI PAUL
A - Grant
Stock Option (Right to buy)
7,650
$0.00
1
$650.9M
2020-01-02
2020-01-06
THOMPSON PETER
A - Grant
Stock Option (Right to buy)
7,650
$0.00
1
$650.9M
2020-01-02
2020-01-06
TOPPER JAMES
A - Grant
Stock Option (Right to buy)
7,650
$0.00
1
$650.9M
2020-01-02
2020-01-06
VENKATESAN JAY
A - Grant
Stock Option (Right to buy)
7,650
$0.00
1
$650.9M